BusinessNovo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition IntensifiesBy Riza DagocDec 31, 2025, 1:51 AM UTC
GovernanceVanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four DecadesBy Riza DagocDec 31, 2025, 1:47 AM UTC
BusinessNovo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and MounjaroBy Riza DagocDec 30, 2025, 10:50 AM UTC
BusinessRoyalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC TherapeuticsBy Riza DagocDec 30, 2025, 2:39 AM UTC
BusinessSanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine PortfolioBy Riza DagocDec 25, 2025, 2:04 AM UTC
HealthGLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025By Riza DagocDec 25, 2025, 1:49 AM UTC
BusinessSanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines PortfolioBy Riza DagocDec 24, 2025, 11:06 AM UTC
GovernanceFDA Approves Mitapivat for Anemia in Thalassemia PatientsBy Riza DagocDec 24, 2025, 5:24 AM UTC
